Quarterly report pursuant to Section 13 or 15(d)

9. Supplemental Disclosure of Cash Flow Information

v3.5.0.2
9. Supplemental Disclosure of Cash Flow Information
9 Months Ended
Sep. 30, 2016
Supplemental Cash Flow Elements [Abstract]  
Supplemental Disclosure of Cash Flow Information

    Nine Months Ended September 30,  
    2016     2015  
Cash paid for interest   $ 1,237,622     $ 222,898  
Cash paid for income taxes   $     $ 1,853,408  
                 
Non-cash investing and financing activities:                
Accrued liabilities settled through the issuance of common stock and warrants   $ 2,131,829     $ –   
Exercise of stock options as reduction of notes payable, related party   $     $ (2,500,000 )
Assets acquired through capital leases   $     $ 1,597,063  
                 
Acquisition of noncontrolling interest in Biohealth Medical Laboratory, Inc.:                
Deposits on acquisition   $     $ 259,875  
Goodwill   $     $ (138,871 )
Noncontrolling interest   $     $ (121,004 )